Journal article

Gabapentin versus lamotrigine monotherapy: A double-blind comparison in newly diagnosed epilepsy

MJ Brodie, TW Chadwick, H Anhut, A Otte, SL Messmer, S Maton, W Sauermann, G Murray, EA Garofalo

EPILEPSIA | BLACKWELL PUBLISHING INC | Published : 2002

Abstract

PURPOSE: This randomised, double-blind study compared the newer antiepileptic drugs (AEDs) gabapentin (GBP) and lamotrigine (LTG) as monotherapy in newly diagnosed epilepsy. METHODS: Patients with partial seizures with and/or without secondary generalization or primary generalized tonic-clonic seizures were randomized to either GBP or LTG. During 2- and 6-week titration periods, respectively, GBP dosage reached 1,800 mg/day, and LTG, 150 mg/day. In the subsequent 24-week maintenance phase, the dose could be adjusted based on seizure control or adverse events between 1,200 and 3,600 mg/day for GBP and 100 and 300 mg/day for LTG. The primary end point was time to exit, a composite of efficacy ..

View full abstract

University of Melbourne Researchers